Surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care

The first three patients to undergo an investigational surgical procedure for peripheral vascular disease that involves the patient's own stem cells continue to do well, say doctors . The "TGI-PVG IDE" clinical trial initiated at the University of Louisville involves using a patient's own stem cells to line man-made bypass grafts to better the chances at saving the limbs of patients with peripheral artery disease.

Read the whole article on Science Daily

More from Science Daily